Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

How the pharmaceutical industry changed psychiatry

Jan Henderson, PhD
Meds
December 3, 2010
Share
Tweet
Share

What’s happened to psychiatry over the last 15 to 20 years? That’s a big subject, discussed in many recent and excellent books. One of those books is by Daniel Carlat, author of Unhinged: The Trouble with Psychiatry – A Doctor’s Revelations about a Profession in Crisis.

One of the problems Carlat readily acknowledges is that psychiatry is excessively focused on psychopharmaceuticals at the expense of other effective treatments. Not only is there too much focus on drugs as treatment. There’s so much money flowing from the pharmaceutical industry to psychiatrists that it makes one wonder if the profession can be objective.

Evidence of financial ties was documented by clinical psychologist Lisa Cosgrove. She considered those psychiatric experts who were responsible for the diagnostic criteria in the DSM, the bible of psychiatric disorders. Of the 170 psychiatrists who contributed their expertise on mood and psychotic disorders, 100% had financial ties to drug companies.

Carlat asks, “Why do psychiatrists take more money from the pharmaceutical industry than other doctors?” His answer:

Our diagnoses are subjective and expandable, and we have few rational reasons for choosing one treatment over another. This makes us ideal prey for marketers who are happy to provide us with a false sense of therapeutic certainty, as long as that certainty results in their drug being prescribed. Furthermore, psychiatrists feel inferior and less ‘medical’ than other specialties. Working at high levels with drug companies gives us a sense of power and prestige that is otherwise missing.

The education of a psychiatrist

Part of that sense of feeling inferior starts in med school. Carlat offers a number of reasons why medical school is not good for psychiatrists:

  • It creates an excessively biomedical view of problems that actually have many other sources (like conditions of daily life).
  • Psychiatrists feel inferior to other doctors. (In the medical school pecking order, only the failures go into psychiatry. See Sandeep Jauhar’s comments in Intern: A Doctor’s Initiation.)
  • Psychiatrists feel superior to other mental health workers because they went to medical school.
  • The time and effort spent on medical school could be much better spent on activities directly related to what psychiatrists go on to practice. (They won’t be called on to deliver babies or perform surgery, for example.)

The med school experience explains, in part, why psychiatrists are antagonistic to colleagues in related disciplines, such as psychotherapists or clinical psychologists. What’s also going on there, however, is that psychiatrists feel a need to protect their own turf. Studies that show therapy or cognitive behavioral training is as effective as drugs are not in the interest of psychiatry.

The felt need to be scientific and biomedical – to be more “medical” than thou – is unfortunate. Psychiatry deals with the human condition, the human soul. When psychiatrists feel a need to insist that they are just as “medical” as other MDs, they no longer acknowledge that psychiatry is and should be essentially different from other medical pursuits.

The biological basis of psychiatric disorders

Modern psychiatry seems to believe that every deviation from “normal” can be explained exclusively by neurological activity in the brain and can be treated by drugs that modify that activity – depression being the main disorder that gets treated these days. Carlat, despite offering criticism of his profession on many counts, subscribes to this view wholeheartedly. “How could mental illness not be, ultimately, biological?” he says. And again, “Undoubtedly, there are both neurobiological and genetic causes for all mental disorders.”

It seems to me there’s a distinction between biological effects and biological causes. Childhood abuse and the trauma of combat may have a biological effect on the brain, but should a psychiatrist offer treatment only after the biological damage has been done? If the only tool the psychiatrist has is psychopharmaceutical modification, then the answer is yes.

Something has happened to psychiatry in recent years that’s not good for either practitioners or patients. Something needs to change. The “bar room brawl” (as Carlat calls it) over revising the next edition of the DSM is probably the best thing that could happen to psychiatry.

ADVERTISEMENT

Jan Henderson is a historian of medicine who blogs at The Health Culture.

Submit a guest post and be heard.

Prev

Should nurses become doctors to save primary care?

December 3, 2010 Kevin 41
…
Next

Appendicitis in children and radiation exposure from CT scans

December 3, 2010 Kevin 11
…

Tagged as: Medications

Post navigation

< Previous Post
Should nurses become doctors to save primary care?
Next Post >
Appendicitis in children and radiation exposure from CT scans

ADVERTISEMENT

More by Jan Henderson, PhD

  • a desk with keyboard and ipad with the kevinmd logo

    Is medicine a science?

    Jan Henderson, PhD
  • a desk with keyboard and ipad with the kevinmd logo

    For doctors who suffer from burnout, the ultimate tragedy is suicide

    Jan Henderson, PhD
  • a desk with keyboard and ipad with the kevinmd logo

    Doctors are asking whether the physical exam is becoming a lost art

    Jan Henderson, PhD

More in Meds

  • Are you neurodivergent or just bored?

    Martha Rosenberg
  • Pharmacy benefit manager reform vs. direct drug plans

    Leah M. Howard, JD
  • A cautionary tale about pramipexole

    Anonymous
  • My persistent adverse reaction to an SSRI

    Scott McLean
  • Tofacitinib: a lesson in heart-immune health

    Larry Kaskel, MD
  • The case for regulating, not banning, kratom

    Heidi Sykora, DNP, RN
  • Most Popular

  • Past Week

    • How to fight for your loved one during a medical crisis [PODCAST]

      The Podcast by KevinMD | Podcast
    • A new autism care model in Idaho

      Ronald L. Lindsay, MD | Conditions
    • Protecting elder clinicians from violence

      Gerald Kuo | Conditions
    • China’s health care model of scale and speed

      Myriam Diabangouaya, MD & Vikram Madireddy, MD | Physician
    • The myth of endless availability in medicine

      Emmanuel Chilengwe | Conditions
    • Bureaucratic evil in modern health care

      Dr. Bryan Theunissen | Conditions
  • Past 6 Months

    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • The decline of the doctor-patient relationship

      William Lynes, MD | Physician
    • Rethinking cholesterol and atherosclerosis

      Larry Kaskel, MD | Conditions
  • Recent Posts

    • How to fight for your loved one during a medical crisis [PODCAST]

      The Podcast by KevinMD | Podcast
    • Is trauma surgery a dying field?

      Farshad Farnejad, MD | Physician
    • Gen Z, ADHD, and divided attention in therapy

      Ronke Lawal | Conditions
    • Innovation in medicine: 6 strategies for docs

      Jalene Jacob, MD, MBA | Tech
    • Why we fund unproven autism therapies

      Ronald L. Lindsay, MD | Physician
    • Early-onset breast cancer: a survivor’s story

      Sara Rands | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 15 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • How to fight for your loved one during a medical crisis [PODCAST]

      The Podcast by KevinMD | Podcast
    • A new autism care model in Idaho

      Ronald L. Lindsay, MD | Conditions
    • Protecting elder clinicians from violence

      Gerald Kuo | Conditions
    • China’s health care model of scale and speed

      Myriam Diabangouaya, MD & Vikram Madireddy, MD | Physician
    • The myth of endless availability in medicine

      Emmanuel Chilengwe | Conditions
    • Bureaucratic evil in modern health care

      Dr. Bryan Theunissen | Conditions
  • Past 6 Months

    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • The decline of the doctor-patient relationship

      William Lynes, MD | Physician
    • Rethinking cholesterol and atherosclerosis

      Larry Kaskel, MD | Conditions
  • Recent Posts

    • How to fight for your loved one during a medical crisis [PODCAST]

      The Podcast by KevinMD | Podcast
    • Is trauma surgery a dying field?

      Farshad Farnejad, MD | Physician
    • Gen Z, ADHD, and divided attention in therapy

      Ronke Lawal | Conditions
    • Innovation in medicine: 6 strategies for docs

      Jalene Jacob, MD, MBA | Tech
    • Why we fund unproven autism therapies

      Ronald L. Lindsay, MD | Physician
    • Early-onset breast cancer: a survivor’s story

      Sara Rands | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

How the pharmaceutical industry changed psychiatry
15 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...